PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26086150-0	2015	Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.	Trimethoprim, Sulfamethoxazole Drug Combination	38-52	major histocompatibility complex, class II, DR beta 1	Homo sapiens	10-13	
26086150-4	2015	This study investigated the association between the HLA class I and HLA-DRB1 polymorphisms and co-trimoxazole-induced SJS/TEN in a Thai population.	Trimethoprim, Sulfamethoxazole Drug Combination	95-109	major histocompatibility complex, class II, DR beta 1	Homo sapiens	52-55	
26086150-4	2015	This study investigated the association between the HLA class I and HLA-DRB1 polymorphisms and co-trimoxazole-induced SJS/TEN in a Thai population.	Trimethoprim, Sulfamethoxazole Drug Combination	95-109	major histocompatibility complex, class II, DR beta 1	Homo sapiens	68-76	
26086150-10	2015	CONCLUSION: Evidence of associations between co-trimoxazole-induced SJS/TEN and HLA alleles including HLA-B*15:02, HLA-C*06:02, and HLA-C*08:01 were found in the study population.	Trimethoprim, Sulfamethoxazole Drug Combination	45-59	major histocompatibility complex, class II, DR beta 1	Homo sapiens	80-83	
19374512-0	2009	TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.	Trimethoprim, Sulfamethoxazole Drug Combination	97-110	major histocompatibility complex, class II, DR beta 1	Homo sapiens	21-24	
19374512-4	2009	The aim of the study was to determine whether functional polymorphisms in TNF, LTA, HSPA1L and HLA-DRB1 genes influence the risk of cotrimoxazole hypersensitivity in HIV-infected patients.	Trimethoprim, Sulfamethoxazole Drug Combination	132-145	major histocompatibility complex, class II, DR beta 1	Homo sapiens	95-103